Literature DB >> 21140359

First successful use of the new ab5000 portable circulatory support console as bridge to recovery in a case of dilated cardiomyopathy.

Lenard Conradi1, Johannes Schirmer, Beate Reiter, Hendrik Treede, Mathias Kubik, Hermann C Reichenspurner, Florian M Wagner.   

Abstract

INTRODUCTION: Growing clinical experience and improved technology have led to more widespread use of ventricular assist devices in patients with end-stage heart failure.
METHODS: We report the case of a patient with preexisting cardiomyopathy who arrived at our center in cardiogenic shock and received a biventricular assist device.
RESULTS: The new compact Abiomed Portable Circulatory Support Console facilitated mobilization of the patient which was particularly advantageous in the face of transient hemiparesis. After recovery from cardiogenic shock, device removal was performed following a bridge-to-recovery concept. He was discharged in a state of full cardiac recompensation and is back to everyday life with stable cardiac function up to 24 months after the incident.
CONCLUSIONS: This is the first report describing successful clinical use of the AB5000 assist device in combination with the portable console. Furthermore, it underlines the potential of temporary circulatory support to induce permanent myocardial recovery even in cases of preexisting cardiomyopathy.

Entities:  

Mesh:

Year:  2010        PMID: 21140359

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  2 in total

Review 1.  Current status of extracorporeal ventricular assist devices in Japan.

Authors:  Takashi Nishimura
Journal:  J Artif Organs       Date:  2014-06-22       Impact factor: 1.731

2.  Acoustic system for the estimation of the temporary blood chamber volume of the POLVAD heart supporting prosthesis.

Authors:  Grzegorz Konieczny; Zbigniew Opilski; Tadeusz Pustelny; Maciej Gawlikowski
Journal:  Biomed Eng Online       Date:  2012-09-21       Impact factor: 2.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.